Zydus Lifesciences informs about press release
Zydus Lifesciences has informed that it enclosed a copy of press release dated March 21, 2026, titled ‘Zydus launches Semaglutide Injection in an innovative, reusable multi-dose pen device in India’.
The above information is a part of company’s filings submitted to BSE.
